Results 251 to 260 of about 29,283 (270)

A systematic review and meta-analysis of the association between circulating tumor DNA (ctDNA) and prognosis in pancreatic cancer

Critical Reviews in Oncology/Hematology, 2021
Suayib Yalcin, Taha Koray Şahin, Deniz Can Güven   +2 more
exaly  

ctDNA guides anti-EGFR rechallenge

Nature Reviews Clinical Oncology, 2022
openaire   +2 more sources

Prognostic value of ctDNA detection in patients with early breast cancer undergoing neoadjuvant therapy: A systematic review and meta-analysis

Cancer Treatment Reviews, 2022
Cristina Saura Manich, Mafalda Oliveira, Andrí Papakonstantinou   +2 more
exaly  

Circulating tumour DNA (ctDNA) in metastatic melanoma, a systematic review and meta-analysis

European Journal of Cancer, 2021
Douglas Ward, Eshetu G Atenafu
exaly  

ctDNA prognostiziert Therapieansprechen

Gastro-News
Alexis Wilhelm, Florian Scheufele, Helmut Friess   +2 more
openaire   +1 more source

The Use of ctDNA in the Diagnosis and Monitoring of Hepatocellular Carcinoma—Literature Review

International Journal of Molecular Sciences, 2023
Rafał Patryn, Magdalena Lesniewska, Julia Budzyńska   +2 more
exaly  

Circulating tumour DNA (ctDNA) as a liquid biopsy for melanoma

Cancer Letters, 2017
Mel Ziman, Leslie Calapre, Lydia Warburton   +2 more
exaly  

ctDNA

2008
openaire   +1 more source

CTCs/ctDNA and Brain Metastasis

2022
S. Ray Kenney, Dario Marchetti
openaire   +1 more source

[Clinical utility of ctDNA in lymphoma].

[Rinsho ketsueki] The Japanese journal of clinical hematology
Genetic analysis can provide important information regarding the diagnosis, subtype, and prognosis of lymphoma. There is a growing body of evidence on liquid biopsy using circulating tumor DNA (ctDNA) as an alternative method for genetic analysis. CtDNA is tumor cell-derived DNA that is found unbound in body fluids.
openaire   +1 more source